Literature DB >> 9797677

Systemic corticosteroid therapy--side effects and their management.

R M Stanbury1, E M Graham.   

Abstract

The anti-inflammatory effects of corticosteroids cannot be separated from their metabolic effects as all cells use the same glucocorticoid receptor; therefore when corticosteroids are prescribed measures should be taken to minimise their side effects. Clearly, the chance of significant side effects increases with the dose and duration of treatment and so the minimum dose necessary to control the disease should be given. Before embarking on a long term course of corticosteroids the factors summarised in Table 1 should be considered. A full discussion with the patient is necessary in order to explain the benefits and risks of corticosteroid treatment. A patient information leaflet is now provided by the manufacturers of all systemic corticosteroid preparations. As emphasised by the recent publication by the Committee on the Safety of Medicines, advice to patients is the key to the safe use of long term systemic corticosteroids and it recommends discussing the following points with the patient: not to stop taking corticosteroids suddenly to see a doctor if they become unwell of the increased susceptibility to infections, especially chickenpox of the serious side effects that may occur to read and keep the patient information leaflet to always carry the steroid treatment card and to show it to any health professional involved in their treatment. In addition the following suggestions may help to minimise some side effects: a single morning dose early dietary modification--low calorie, low sodium, and high potassium awareness of possible errors of judgment on high doses. Once started on corticosteroids the patient should be regularly reviewed to assess the response to the treatment with adjustments to keep the dose at a minimum.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9797677      PMCID: PMC1722622          DOI: 10.1136/bjo.82.6.704

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  26 in total

1.  Hormone replacement therapy for all? Universal prescription is desirable.

Authors:  P Toozs-Hobson; L Cardozo
Journal:  BMJ       Date:  1996-08-10

Review 2.  Special considerations in the use of glucocorticoids in children.

Authors:  J D Spahn; A K Kamada
Journal:  Pediatr Rev       Date:  1995-07

Review 3.  Avascular necrosis of the hip.

Authors:  R R Coombs; R W Thomas
Journal:  Br J Hosp Med       Date:  1994 Mar 16-Apr 5

4.  Near fatal chickenpox during prednisolone treatment.

Authors:  P Rice; K Simmons; R Carr; J Banatvala
Journal:  BMJ       Date:  1994-10-22

5.  Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin.

Authors:  P Sambrook; J Birmingham; P Kelly; S Kempler; T Nguyen; N Pocock; J Eisman
Journal:  N Engl J Med       Date:  1993-06-17       Impact factor: 91.245

Review 6.  Corticosteroids and tuberculosis.

Authors:  T Senderovitz; K Viskum
Journal:  Respir Med       Date:  1994-09       Impact factor: 3.415

7.  The efficacy of systemic corticosteroids in sight-threatening retinal vasculitis.

Authors:  L J Howe; M R Stanford; C Edelsten; E M Graham
Journal:  Eye (Lond)       Date:  1994       Impact factor: 3.775

8.  Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis.

Authors:  A Struys; A A Snelder; H Mulder
Journal:  Am J Med       Date:  1995-09       Impact factor: 4.965

9.  Testosterone concentrations in men on chronic glucocorticosteroid therapy.

Authors:  R C Fitzgerald; S J Skingle; A J Crisp
Journal:  J R Coll Physicians Lond       Date:  1997 Mar-Apr

Review 10.  Steroid-induced osteonecrosis of the humeral head.

Authors:  B W Usher; R J Friedman
Journal:  Orthopedics       Date:  1995-01       Impact factor: 1.390

View more
  83 in total

1.  Reliability of expert interpretation of retinal photographs for the diagnosis of toxoplasma retinochoroiditis.

Authors:  M R Stanford; L Gras; A Wade; R E Gilbert
Journal:  Br J Ophthalmol       Date:  2002-06       Impact factor: 4.638

2.  Treatment of non-arteritic anterior ischemic optic neuropathy with high-dose systemic corticosteroids.

Authors:  Gema Rebolleda; Marta Pérez-López; Pilar Casas-Llera; Francisco José Muñoz-Negrete
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-05-29       Impact factor: 3.117

3.  Coincident intra-abdominal presentation of lymphoma and tuberculosis after long-term iatrogenic immunosuppression.

Authors:  Balwant S Negi; Priyanka Thakur; Muninder K Negi; Swaroop Revannasiddaiah
Journal:  BMJ Case Rep       Date:  2012-02-21

4.  The role of mucosal healing in the treatment of patients with inflammatory bowel disease.

Authors:  Byron P Vaughn; Sveta Shah; Adam S Cheifetz
Journal:  Curr Treat Options Gastroenterol       Date:  2014-03

5.  Revisiting medication use in a frail 93-year-old man experiencing possible adverse effects.

Authors:  Barbara Farrell; Anne Monahan; Wade Thompson
Journal:  CMAJ       Date:  2013-10-21       Impact factor: 8.262

6.  Steroid differentiation: the safety profile of various steroids on retinal cells in vitro and their implications for clinical use (an American Ophthalmological Society thesis).

Authors:  Baruch D Kuppermann; Leandro Cabral Zacharias; M Cristina Kenney
Journal:  Trans Am Ophthalmol Soc       Date:  2014-07

Review 7.  Biologic agents in experimental autoimmune uveitis.

Authors:  Gian Paolo Giuliari; Ama Sadaka; David M Hinkle
Journal:  Int Ophthalmol       Date:  2013-03-14       Impact factor: 2.031

8.  Dexamethasone-mediated changes in adipose triacylglycerol metabolism are exaggerated, not diminished, in the absence of a functional GR dimerization domain.

Authors:  Donald J Roohk; Smita Mascharak; Cyrus Khambatta; Ho Leung; Marc Hellerstein; Charles Harris
Journal:  Endocrinology       Date:  2013-03-14       Impact factor: 4.736

9.  Ligand-induced repression of the glucocorticoid receptor gene is mediated by an NCoR1 repression complex formed by long-range chromatin interactions with intragenic glucocorticoid response elements.

Authors:  Sivapriya Ramamoorthy; John A Cidlowski
Journal:  Mol Cell Biol       Date:  2013-02-19       Impact factor: 4.272

Review 10.  Treatment of ocular inflammation in children.

Authors:  Sunil M Thadani; C Stephen Foster
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.